Johnson Paula I, Sutton Patrice, Atchley Dylan S, Koustas Erica, Lam Juleen, Sen Saunak, Robinson Karen A, Axelrad Daniel A, Woodruff Tracey J
Program on Reproductive Health and the Environment, University of California, San Francisco, Oakland, California, USA.
Environ Health Perspect. 2014 Oct;122(10):1028-39. doi: 10.1289/ehp.1307893. Epub 2014 Jun 25.
The Navigation Guide methodology was developed to meet the need for a robust method of systematic and transparent research synthesis in environmental health science. We conducted a case study systematic review to support proof of concept of the method.
We applied the Navigation Guide systematic review methodology to determine whether developmental exposure to perfluorooctanoic acid (PFOA) affects fetal growth in humans.
We applied the first 3 steps of the Navigation Guide methodology to human epidemiological data: 1) specify the study question, 2) select the evidence, and 3) rate the quality and strength of the evidence. We developed a protocol, conducted a comprehensive search of the literature, and identified relevant studies using prespecified criteria. We evaluated each study for risk of bias and conducted meta-analyses on a subset of studies. We rated quality and strength of the entire body of human evidence.
We identified 18 human studies that met our inclusion criteria, and 9 of these were combined through meta-analysis. Through meta-analysis, we estimated that a 1-ng/mL increase in serum or plasma PFOA was associated with a -18.9 g (95% CI: -29.8, -7.9) difference in birth weight. We concluded that the risk of bias across studies was low, and we assigned a "moderate" quality rating to the overall body of human evidence.
On the basis of this first application of the Navigation Guide systematic review methodology, we concluded that there is "sufficient" human evidence that developmental exposure to PFOA reduces fetal growth.
开发导航指南方法是为了满足环境卫生科学中对系统且透明的研究综合方法的需求。我们进行了一项案例研究系统评价,以支持该方法的概念验证。
我们应用导航指南系统评价方法来确定发育过程中接触全氟辛酸(PFOA)是否会影响人类胎儿生长。
我们将导航指南方法的前三个步骤应用于人类流行病学数据:1)明确研究问题,2)选择证据,3)评估证据的质量和强度。我们制定了方案,对文献进行全面检索,并使用预先设定的标准确定相关研究。我们评估每项研究的偏倚风险,并对一部分研究进行荟萃分析。我们对整个人类证据的质量和强度进行了评级。
我们确定了18项符合纳入标准的人类研究,其中9项通过荟萃分析进行了合并。通过荟萃分析,我们估计血清或血浆中PFOA每增加1 ng/mL,出生体重差异为-18.9 g(95% CI:-29.8,-7.9)。我们得出结论,各项研究的偏倚风险较低,我们将整个人类证据的质量评级定为“中等”。
基于对导航指南系统评价方法的首次应用,我们得出结论,有“充分”的人类证据表明发育过程中接触PFOA会降低胎儿生长。